PROCEPT (PRCT) Director Elisabeth Sandoval Receives RSU Award

What Happened

• Director Elisabeth Sandoval was granted two awards on June 9, 2026: 3,315 restricted stock units (RSUs) and 5,853 derivative awards (both reported as acquisitions at $0.00). The filing shows $0 paid for these grants — they are compensation awards, not open‑market purchases or sales.

Key Details

• Transaction date: 2026-06-09; Form 4 filed 2026-06-10 (timely filing).
• Awards: 3,315 RSUs (reported as shares) and 5,853 derivative securities; reported acquisition price $0.00 for both (no cash paid).
• Vesting: Per footnotes, the RSUs and the derivative/option vest in full on the earlier of (i) the one‑year anniversary of the grant or (ii) the date of the next annual meeting, subject to continued service.
• Shares owned after transaction: Not disclosed in the provided filing excerpt.
• Footnotes: F1 clarifies the 3,315 securities are RSUs convertible to one share each upon vesting. F2 notes the derivative award was granted June 9, 2026, and shares the same vesting schedule (described as a stock option in the filing).
• Filing timeliness: Filed the next day (appears timely); no late‑filing indication in the data provided.

Context

• These grants are standard equity compensation for insiders and do not represent a market purchase or sale. RSUs convert to actual shares only upon vesting; derivative awards described as options may require exercise per their terms. Such awards are common for retention/compensation and should be interpreted as part of insider pay rather than an immediate bullish or bearish trade signal.